EFNA4
Ephrin-A4
Also known as: EFNA4_HUMAN, EPLG4, LERK4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52798
- Gene
- EFNA4
- Ensembl
- ENSG00000243364
- Chromosome
- 1
- Canonical length
- 201 aa
- Protein class
- Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin that has been implicated in proliferation and metastasis of several types of cancers. [provided by RefSeq, May 2022]
Canonical amino-acid sequenceUniProt
201 residues, UniProt reviewed canonical sequence.
>P52798|EFNA4
1 MRLLPLLRTV LWAAFLGSPL RGGSSLRHVV YWNSSNPRLL RGDAVVELGL NDYLDIVCPH
61 YEGPGPPEGP ETFALYMVDW PGYESCQAEG PRAYKRWVCS LPFGHVQFSE KIQRFTPFSL
121 GFEFLPGETY YYISVPTPES SGQCLRLQVS VCCKERKSES AHPVGSPGES GTSGWRGGDT
181 PSPLCLLLLL LLLILRLLRI LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EFNA4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- skin: 29 nTPM
- esophagus: 18 nTPM
- vagina: 14 nTPM
- salivary gland: 13 nTPM
- cervix: 12 nTPM
- epididymis: 12 nTPM
Single-cell type
- microglia: 2.2 nCPM
- astrocytes: 1.7 nCPM
- ependymal cells: 1.7 nCPM
- choroid plexus epithelial cells: 1.3 nCPM
- gastric chief cells: 1.1 nCPM
- oligodendrocytes: 1.1 nCPM
Immune cell
- plasmacytoid DC: 25 nTPM
- memory B-cell: 23 nTPM
- naive B-cell: 17 nTPM
- non-classical monocyte: 14 nTPM
- naive CD4 T-cell: 12 nTPM
- neutrophil: 11 nTPM
Brain region
- choroid plexus: 4.4 nTPM
- medulla oblongata: 2.6 nTPM
- white matter: 2.5 nTPM
- pons: 2.4 nTPM
- midbrain: 2.3 nTPM
- spinal cord: 2.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.46
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.76
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EFNA4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EFNA4 as an antibody target. Whether an autoantibody or antibody against EFNA4 could matter depends on whether native EFNA4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EFNA4 is annotated at the cell surface, where native EFNA4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EFNA4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...